UBS Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,853,356
Closed -$1.21B 8714
2020
Q1
$1.21B Buy
6,853,356
+429,597
+7% +$80.9M 0.74% 29
2019
Q4
$1.23B Buy
6,423,759
+755,331
+13% +$136M 0.54% 41
2019
Q3
$954M Sell
5,668,428
-1,472,121
-21% -$240M 0.46% 56
2019
Q2
$1.2B Buy
7,140,549
+5,506,943
+337% +$763M 0.56% 44
2019
Q1
$239M Buy
1,633,606
+715,209
+78% +$104M 0.12% 200
2018
Q4
$123M Sell
918,397
-275,486
-23% -$45.2M 0.07% 321
2018
Q3
$227M Sell
1,193,883
-305,176
-20% -$56.1M 0.11% 221
2018
Q2
$250M Sell
1,499,059
-168,401
-10% -$27M 0.13% 200
2018
Q1
$281M Buy
1,667,460
+468,124
+39% +$78.5M 0.16% 190
2017
Q4
$196M Buy
1,199,336
+40,747
+4% +$7.31M 0.11% 251
2017
Q3
$237M Sell
1,158,589
-123,304
-10% -$28.7M 0.14% 197
2017
Q2
$312M Buy
1,281,893
+138,305
+12% +$32.5M 0.2% 158
2017
Q1
$273M Sell
1,143,588
-81,244
-7% -$18.9M 0.18% 168
2016
Q4
$257M Buy
1,224,832
+3,148
+0.3% +$652K 0.18% 164
2016
Q3
$281M Sell
1,221,684
-74,962
-6% -$18.3M 0.21% 145
2016
Q2
$300M Buy
1,296,646
+172,869
+15% +$39.9M 0.23% 123
2016
Q1
$301M Sell
1,123,777
-7,613
-0.7% -$2.18M 0.24% 115
2015
Q4
$354M Sell
1,131,390
-408,899
-27% -$122M 0.28% 93
2015
Q3
$419M Sell
1,540,289
-58,305
-4% -$17.9M 0.36% 60
2015
Q2
$485M Sell
1,598,594
-31,939
-2% -$9.53M 0.38% 51
2015
Q1
$485M Buy
1,630,533
+631,134
+63% +$180M 0.39% 52
2014
Q4
$257M Buy
+999,399
New +$250M 0.22% 132

Other funds holding AGN